Sandbox Reserved 1656

This Sandbox is Reserved from 26/11/2020, through 26/11/2021 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1643 through Sandbox Reserved 1664.

To get started: Click the edit this page tab at the top. Save the page after each step, then edit it again. Click the 3D button (when editing, above the wikitext box) to insert Jmol. show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page. Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc. More help: Help:Editing

Deubiquitinases

spinqualitylabelsall models The catalytic domain of human deubiquitinase DUBA in complex with ubiquitin aldehyde Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Deubiquitinating enzymes or Deubiquitinases (DUBs) are enzymes with an ubiquitin-dependent action. More than a hundred DUBs genes are known to be encoded by the humans genome, making it a very large protein family. This diversity allows targeted actions and a certains specificity. DUBs's main role is about cleaving specially ubiquitin-linked molecules, which are most of the time a protein. The fate of an ubiquitin-tagged protein depends in part of the length of the ubiquitin chain(s) and on the configuration of ubiquitin-ubiquitin linkages in the chain considered. The tag is going in particular to regulate the degradation of the tagged-molecule by the proteasome or lysozyme, influence its cellular localisation or modulates the activity with another protein. Generalities Function Deubiquitinases are key enzymes belonging to the vast group of proteases.They take part in the removal of ubiquitin molecules on proteins which have been ubiquitinated, allowing the degradation of ubiquitin-tagged proteins. As a result, these enzymes play an important role being implicated in the regulation of protein degradation. Indeed, the pathway for a protein to be degraded involves, an enzymatic cascade that will add a poly-ubiquitin fragment to the protein. This mechanism is called ubiquitination(fr) (en). Following this step, mono or poly-ubiquitin is by deubiquitinases from the protein. Classes Deubiquitinases belong to the large protease family. This family gathers into five classes,all of them definded according to the nature of the amino acid composition of their active site carrying out the catalysis. It can be either : serine proteases, cysteine proteases, acid proteases, metalloproteases, or threonine proteases. DUBs belong to only two of these families: metalloproteases and cysteine proteases. Among the cysteine proteins, four subfamilies can be described according to their catalytic domains: ubiquitin-specific proteases (USPs),the Ubiquitin C-terminal hydrolases (UCHs),Ovarian tumore-related proteases (OTUs) and Machado-Joseph disease proteases (MJD). The deubiquitinases belonging to the family of metalloproteases all have a JAMM catalytic domain (JAB1/MPN/Mov34 metalloenzyme). Within these two families, DUBs are classified into subfamilies according to the differences in their amino acid sequences surrounding the catalytically active amino acid residues. Localization The localization depends on the DUB we consider. Nevertheless, the majority of DUBs are found in the nucleus, plasma membrane and/or in secretory and endocytic pathways. For example, in the ubiquitin-specific proteases family (UPSs), USP21 is mostly associated with microtubules and the centrosome. Thus this deubiquitinase is highly dependent on all the physiological mechanisms involving the microtubules. Structure The overall structure 3TMP is the catalytic domain of human deubiquitinase DUBA in complex with ubiquitin aldehyde. It is a 8-chain-structure with sequences from Human. Indeed, 3TMP is made of two macromolecules : OTU domain-containing protein 5 (also named DUBA or OTUD5) and Polyubiquitin-C, which is the ubiquitin aldehyde. The catalytic domain is also composed of two small molecules the phosphoserine (SEP) and the amino-acetaldehyde (GLZ),which they are L-peptide links. Impact of phosphorylation on DUB activity Evidence shows that phosphorylation influences enzyme activity. Phosphorylated serine seems to have the most influence on the enzyme activity especially on Ser177. The phosphorylation of this nucleotide is crucial to the protein to work. In fact, this part bends to welcome the protein to be deubiquitinated. Catalytic domain The DUB family is determined by the catalytic domain. Indeed, DUBs belonging to the family of cysteine proteases have a catalytic site composed of two or three amino acids (dyads or triads). When the catalytic site is active, it may contain cysteine, histidine, aspartate or asparagine residues. As far as the metalloproteases are concerned, their active site is composed of a zinc ion and amino acids such as histidine, aspartate and serine. The studied structure shows both the catalytic site (in orange) and polyubiquitine (in purple). Residues present in the catalytic site of DUBs are often in a non-functional orientation in the absence of substrate. As a result, when the substrate binds to the catalytic site of the enzyme, the site undergoes rearrangements and takes on a functional conformation. The substrate opens and closes to allow the entry of the protein to be deubiquitinased. The enzyme takes this configuration thanks to many hydrogen bonds around Ser177. This is why phosphorylation is so important to the function of the enzyme. The phosphate group forms many links between substrate ubiquitin and a segment of the OTU domain. This is rare among the known structures of deubiquitinases. Phosphorylation-driven conformational change resembles to the one of kinases. Biological role DUBs are involved at multiple levels in the ubiquitin pathway. The modifications made by DUBs are post-translational modifications. Depending on the level, DUBs have different functions. Two specific cellular functions exist for deubiquitinases. They may act either on the degradation of the stabilization of a substrate in particular (réf 15 à ajoutées). Further functions are more specifically related to the ubiquitin molecule. Here are some of them : A : maturation of ubiquitin. When ubiquitin molecules are synthesized, they are not in free form. Thus, DUBs are essential for the generation of free monomers from precursors. The degradation of precursors is carried out by several DUBs belonging to the USPs class. B : cleavage between protein and mono-ubiquitin and regulation of the poly-ubiquitin chain. DUBs also have a regulatory activity because they allow the elimination of ubiquitin chains mistakenly conjugated to substrates. C : cleavage between protein and poly-ubiquitin chain. Once the protein has been degraded by the proteasome or autophagolysosome, DUBs allow the polyubiquitin chain to be separated from the protein. D : recycling of ubiquitin. Certain deubiquitinases allow the separation of polyubiquitin chains in order to release ubiquitin monomers. Figure 1 : Role of DUBs in the ubiquitin pathways Some other deubiquitinating enzymes also have biological functions. The latter are for instance involved in growth control, transcription silencing, regulation and viral infection or even the processing of ubiquitin-like-modifications. (réf 15 à ajoutées) Disease The involvement of deubiquitinases in diseases is still poorly understood. However, it is known that they play a role in various physiological processes, particularly in the case of cancers. In fact, DUBs have a role in the mechanism involved in histone modification and so have influence on tumor development and progression. For instance, in gastric cancer, DUBs are regulated upwards and DUBs are related to tumor size. Otubain 1 The enzyme Otubain 1 is a deubiquitinase belonging to the Otubain family of proteases. The role of OTUB1 is not yet clearly defined, some studies show the correlation between tumour growth and OTUB1 while others show no involvement or suppression of the tumour by this enzyme. This suggests that the effects of OTUB1 depend on the stage and the tumour itself. However, the therapeutic targeting of OTUB1 could be used for patients with various tumours, since the enzyme is found in many tissues and has a high level of cell expression.